Subcutaneous Talquetamab in Elderly Patients With Multiple Myeloma in Early Relapse

Clinical trial NCT06827860 · RECRUITING

Trial details

NCT number: NCT06827860
Sponsor: Larysa Sanchez
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Multiple Myeloma in Relapse

Start date: 2025-11-18
Primary completion: 2027-01-01
Enrollment: 23

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.